| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,981 |
3,612 |
$160K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,785 |
4,248 |
$106K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,286 |
4,126 |
$71K |
| 80061 |
Lipid panel |
4,547 |
4,357 |
$61K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,421 |
6,887 |
$57K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
832 |
758 |
$40K |
| 80053 |
Comprehensive metabolic panel |
3,738 |
3,588 |
$39K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
855 |
821 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,923 |
1,843 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,197 |
2,058 |
$18K |
| 86328 |
|
991 |
913 |
$18K |
| 82274 |
|
1,080 |
1,039 |
$17K |
| 81000 |
|
5,127 |
4,862 |
$17K |
| 36415 |
Collection of venous blood by venipuncture |
1,741 |
1,553 |
$11K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
371 |
360 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
700 |
330 |
$8K |
| 86738 |
|
343 |
324 |
$5K |
| 82043 |
|
584 |
559 |
$3K |
| 84153 |
|
179 |
170 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
62 |
62 |
$3K |
| 87088 |
|
325 |
310 |
$3K |
| 84439 |
|
214 |
213 |
$2K |
| 86803 |
|
122 |
120 |
$2K |
| 85651 |
|
515 |
497 |
$2K |
| 82607 |
|
105 |
100 |
$2K |
| 84436 |
|
71 |
62 |
$447.93 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
24 |
24 |
$437.69 |
| 82570 |
|
67 |
66 |
$367.56 |
| 82947 |
|
89 |
84 |
$341.94 |
| 87275 |
|
13 |
13 |
$155.67 |
| 87276 |
|
13 |
13 |
$155.67 |
| 86701 |
|
13 |
13 |
$120.95 |
| 86140 |
|
13 |
13 |
$68.69 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
75 |
68 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
287 |
276 |
$0.00 |